CRAB CTC: Phase I Study of Carfilzomib (C) and Irinotecan (I) in Relapsed Irinotecan-Sensitive Solid Tumors Susanne M. Arnold, MD1; Kari Chansky, PhD2; Markos Leggas, PhD1; Michael Thomson, MD3; John Hamm, MD4; Ra

First Page		Document Content
Date: 2015-08-21 17:45:04		CRAB CTC: Phase I Study of Carfilzomib (C) and Irinotecan (I) in Relapsed Irinotecan-Sensitive Solid Tumors Susanne M. Arnold, MD1; Kari Chansky, PhD2; Markos Leggas, PhD1; Michael Thomson, MD3; John Hamm, MD4; Ra Add to Reading List Source URL: www.crab.org Download Document from Source Website File Size: 368,30 KB Share Document on Facebook